Canadian healthcare providers should mention cardiovascular disease prevention as a benefit when promoting the usefulness of flu vaccines to the public.
The Ontario Pharmacists Association has come out against the new fee, calling it a shift towards ‘U.S. PBM-style operations and business practices into the Canadian market.’